Bepreve

Bepreve is a brand name of bepotastine ophthalmic, approved by the FDA in the following formulation(s):

BEPREVE (bepotastine besilate - solution/drops; ophthalmic)

• 
  Manufacturer: ISTA PHARMS
  
  Approval date: September 8, 2009
  
  Strength(s): 1.5% ^[RLD]

Has a generic version of Bepreve been approved?

No. There is currently no therapeutically equivalent version of Bepreve available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Bepreve. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Acid addition salt of optically active piperidine compound and process for preparing the same
  Patent 6,780,877
  Issued: August 24, 2004
  Inventor(s): Jun-ichiro; Kita & Hiroshi; Fujiwara & Shinji; Takamura
  Assignee(s): Ube Industries, Ltd.
  Tanabe Seiyaku Co., Ltd.
  The present invention is to provide a benzenesulfonic acid salt and a benzoic acid salt of (S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic acid represented by the formula (I): wherein * represents an asymmetric carbon, which are excellent in antihistaminic activity and anti-allergic activity, and a process for producing the same.
  
  Patent expiration dates:
  
  
  • December 25, 2017
    
    ✓ 
    Drug substance
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • September 8, 2014 - NEW CHEMICAL ENTITY
  
  

See also...

• Bepreve Consumer Information (Drugs.com)
• Bepreve Eye Drops Consumer Information (Wolters Kluwer)
• Bepreve Consumer Information (Cerner Multum)
• Bepreve Advanced Consumer Information (Micromedex)
• Bepreve AHFS DI Monographs (ASHP)
• Bepotastine Eye Drops Consumer Information (Wolters Kluwer)
• Bepotastine ophthalmic Consumer Information (Cerner Multum)
• Bepotastine besilate Ophthalmic Advanced Consumer Information (Micromedex)
• Bepotastine Besilate AHFS DI Monographs (ASHP)